The company's upbeat outlook contrasts the uncertainty around 2024 earnings for health insurers staring at the end of COVID-related insurance protection measures and potential declines in government payouts for some plans. US challenges Tennessee ban on healthcare for transgender youth The U.S. Justice Department on Wednesday filed a complaint challenging a new Tennessee law that bans doctors from providing gender-affirming medical treatment such as puberty blockers, hormone therapy and surgery to transgender minors.
New research published in the Frontiers in Pediatrics on pediatric patients with clostridium difficile infections (CDI) could ultimately result in future studies identifying risk factors within the.
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group than the vancomycin group